Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early patient access to health technologies: Is innovation needed for early management?
Adenot I, Camus D, Épis de Fleurian AA, Tassy D; participants of Giens XXXV Round Table 'Health technologies'; Bourguignon S, Chabin N, Chambrin PY, Costagliola D, Huot L, Joly AS, Le Lous G, Martelli N, Orlikowski D, Petit V, Puc C, Roussel C, Wilquin-Bequet F. Adenot I, et al. Therapie. 2020 Jan-Feb;75(1):71-83. doi: 10.1016/j.therap.2019.11.008. Epub 2019 Dec 16. Therapie. 2020. PMID: 32044105 Review. French.
Les solutions numériques en santé, quelles valeurs apportées, quels mécanismes de financement et quelles évaluations ?
Charle-Maachi C, Moreau-Gaudry A, Sainati D, Camus D, Adenot I, Barthelemy CE, de Chalus T, Debroucker F, Denis F, Gourio C, Habran E, Kamal N, Le Douarin YM, Rosier A, Schuck S, Thébaut JF, Trancart A, Vercamer V. Charle-Maachi C, et al. Among authors: adenot i. Therapie. 2022 Jan-Feb;77(1):117-132. doi: 10.1016/j.therap.2021.12.005. Epub 2021 Dec 6. Therapie. 2022. PMID: 34972582 French. No abstract available.
What value do digital health solutions bring, what are the funding mechanisms and evaluations?
Charle-Maachi C, Moreau-Gaudry A, Sainati D, Camus D, Adenot I, Barthelemy CE, de Chalus T, Debroucker F, Denis F, Gourio C, Habran E, Kamal N, Le Douarin YM, Rosier A, Schuck S, Thébaut JF, Trancart A, Vercamer V. Charle-Maachi C, et al. Among authors: adenot i. Therapie. 2022 Jan-Feb;77(1):133-147. doi: 10.1016/j.therap.2021.12.010. Epub 2021 Dec 16. Therapie. 2022. PMID: 35034780
[The pharmaceutical record].
Adenot I. Adenot I. Ann Pharm Fr. 2007 Sep;65(5):325-30. doi: 10.1016/s0003-4509(07)92595-x. Ann Pharm Fr. 2007. PMID: 17982380 French.
« Intelligence artificielle » : quels services, quelles applications, quels résultats et quelle valorisation aujourd’hui en recherche clinique ? Quel impact sur la qualité des soins ? Quelles recommandations ?
Diebolt V, Azancot I, Boissel FH; Les participants à la table ronde « Sujet d’actualité (2) » des Ateliers de Giens XXXIV. Diebolt V, et al. Therapie. 2019 Feb;74(1):141-154. doi: 10.1016/j.therap.2018.11.006. Epub 2018 Nov 22. Therapie. 2019. PMID: 30711201 French. No abstract available.
[INFORMATION ABOUT DRUGS].
Adenot I. Adenot I. J Int Bioethique Ethique Sci. 2015 Mar;26(1):59-63, 100-1. J Int Bioethique Ethique Sci. 2015. PMID: 26606768 French.